Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. Financials
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization1 6 83716 07132 20232 202-
Enterprise Value (EV)2 6 31814 96423 37812 6485 014
P/E ratio -35,6x1 112x3,65x3,63x6,44x
Yield -----
Capitalization / Revenue 63,0x33,3x1,85x2,06x3,04x
EV / Revenue 58,2x31,0x1,35x0,81x0,47x
EV / EBITDA -42,8x-343x1,70x0,95x0,67x
Price to Book 13,9x11,8x2,83x1,56x1,25x
Nbr of stocks (in thousands) 226 262240 786241 521241 521-
Reference price (EUR) 30,266,7133133133
Announcement Date 03/31/202003/30/2021---
1 USD in Million
2 EUR in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023
Net sales1 10948217 37415 62110 602
EBITDA1 -148-43,713 76613 3087 429
Operating profit (EBIT)1 -182-82,413 50713 2837 311
Operating Margin -167%-17,1%77,7%85,0%69,0%
Pre-Tax Profit (EBT)1 -179-14612 95613 9217 756
Net income1 -17915,29 2209 4315 337
Net margin -165%3,15%53,1%60,4%50,3%
EPS2 -0,850,0636,536,720,7
Dividend per Share2 -----
Announcement Date 03/31/202003/30/2021---
1 EUR in Million
2 EUR
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 2 0485 3096 0874 0074 2213 771
EBITDA1 1 6754 2154 7432 750--
Operating profit (EBIT)1 1 6624 1984 7242 9263 1352 696
Operating Margin 81,1%79,1%77,6%73,0%74,3%71,5%
Pre-Tax Profit (EBT)1 1 6424 0234 6672 4752 6142 623
Net income1 1 1282 7873 2111 9261 8031 810
Net margin 55,1%52,5%52,7%48,1%42,7%48,0%
EPS2 4,3910,812,47,648,525,57
Dividend per Share ------
Announcement Date 05/10/202108/09/202111/09/2021---
1 EUR in Million
2 EUR
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt1 -----
Net Cash position1 5191 1078 82419 55427 188
Leverage (Debt / EBITDA) 3,52x25,4x-0,64x-1,47x-3,66x
Free Cash Flow1 -237-79,58 4298 3525 159
ROE (Net Profit / Equities) -47,1%1,63%141%57,0%18,8%
Shareholders' equity1 3809336 52116 54628 393
ROA (Net Profit / Asset) -24,7%0,98%121%51,8%12,2%
Assets1 7251 5587 60418 21043 726
Book Value Per Share2 2,185,6847,185,6106
Cash Flow per Share2 -0,94-0,0540,542,08,91
Capex1 38,666,0201146155
Capex / Sales 35,5%13,7%1,16%0,94%1,46%
Announcement Date 03/31/202003/30/2021---
1 EUR in Million
2 EUR
Key data
Capitalization (USD) 36 464 850 393
Net sales (EUR) 482 325 000
Net sales (USD) 543 966 135
Number of employees 2 800
Sales / Employee (EUR) 172 259
Sales / Employee (USD) 194 274
Avg. Exchange 20 sessions (EUR) 449 800 997
Avg. Exchange 20 sessions (USD) 507 285 565
Average Daily Capital Traded 1,23%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA